Publications by authors named "Braden O'Neil"
Lancet Respir Med
May 2021
Article Synopsis
- The study investigated the safety and effectiveness of peginterferon lambda, a type III interferon, for treating outpatients with mild-to-moderate COVID-19, given its role in antiviral responses.
- It utilized a double-blind, placebo-controlled method, where patients were randomly assigned to receive either peginterferon lambda or a placebo within a week of showing symptoms.
- Results indicated that by day 7, a higher percentage of patients receiving peginterferon lambda had a significant decrease in viral load compared to the placebo group, suggesting its potential as an effective treatment for COVID-19.
